Categories


-
  • Affordable Educational Credits
  • Watch At Your Convenience
  • Worldwide Speakers
  • Captivating Topics
  • Peer Interactions

Pharmacology & Toxicology for IBCLCs - 3 CERPs

Do you need to expand your understanding in IV. Pharmacology and Toxicology as specified by the IBCLC Detailed Content Outline? If your personalized Professional Development Plan (PPDP) has indicated a requirement for further education in this domain, our 3-hour comprehensive lecture package is an excellent option.

Our package delivers education on the IV. Pharmacology and Toxicology category. Our knowledgeable speakers cover the continuing education requirements for this category, offering you the opportunity to deepen your comprehension and refine your skills in this field.

To ensure the best learning experience, please confirm you haven't already taken any of these lectures at the time of purchase. However, if you encounter any issues after purchase, simply reach out to [email protected], and we'll work to find a suitable replacement for you.

$50.00 USD
Total CE Hours: 3.00   Access Time: 4 Weeks  
Lectures in this bundle (3):
Duration: 60 mins
Medication Use During Breastfeeding

Philip O. Anderson, Pharm.D., FCSHP, FASHP is a Health Sciences Clinical Professor of Pharmacy at the UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences where he heads the course on drug information.
Dr. Anderson has lectured and published extensively on drug use during breastfeeding including in professional journals and textbooks, including original research on drug excretion into breastmilk. Dr. Anderson founded the LactMed® database, which is part of the National Library of Medicine’s Bookshelf. He continues to write LactMed® records and to expand the database. He has authored the medication appendix to the popular handbook, The Nursing Mothers' Companion. Dr. Anderson is the Pharmacology Editor of the professional journal, Breastfeeding Medicine, and writes a monthly column on medication use during breastfeeding for the journal. He has also been a consultant to the US Food and Drug Administration on the topic of drug labeling with respect to use during lactation.

Objective 1: List 3 factors that increase infant impact of a drug in milk;

Objective 2: List 3 strategies to minimize infant intake of drugs in milk;

Objective 3: List the infant age range of greatest risk for drug ingestion while nursing.

Abstract:

Many mothers do not breastfeed their infants, discontinue breastfeeding or fail to take medications while they are breastfeeding. The principles of drug passage into breast milk are well established, although not well known by many health professionals. This presentation will review the principles of drug passage into breast milk, medications and factors that can cause a risk for adverse reactions in breastfed infants and discuss how to choose the most appropriate medications for mothers who are breastfeeding their infants.

View Full Presentation Information
Duration: 60 mins
Marie Zahorick, APRN, MS, FNP-C, IBCLC
Medications and Mothers' Minds: Psychopharmacology for Lactating Mothers
U.S.A. Marie Zahorick, APRN, MS, FNP-C, IBCLC

Marie Zahorick, MS, APRN, FNP-C, IBCLC became a La Leche League Leader in 1999 and an IBCLC in 2005. After several years of working as a hospital-based bilingual Spanish-speaking IBCLC, she attended nursing school and eventually became a board-certified Family Nurse Practitioner. In the meantime, she continued working as a hospital-based lactation consultant doing inpatient, outpatient, and Level III NICU lactation. She did not get much sleep.

After graduate school, Marie was recruited to work as a nurse practitioner in psychiatry. She was fellowship-trained to manage patients in the acute inpatient setting, partial hospitalization, outpatient office, and OB patients in the general hospital setting.

She specializes in women’s psychiatry, especially medical management of women who are pregnant or lactating. Her expertise also includes general psychopharmacology. She is experienced at diagnosing and treating mental conditions such as bipolar disorder, perinatal/postpartum mood and anxiety disorders, postpartum psychosis, obsessive-compulsive disorder, premenstrual and perimenopausal mood disorders, and personality disorders.

She lives in the Chicago area with her husband and three adult children in the transient stage of life. Her children all breastfed for at least two years but now just make faces when confronted with that fact.

Objective 1: List three categories of medications used in psychiatry during the prenatal period and discuss their mechanisms of action.

Objective 2: Report the clinical applications, side effects and potential harm of drugs used in perinatal psychiatry

Objective 3: Access reputable resources in psychopharmacology to help the patient and prescriber assess the risks and benefits of medications and risks and benefits of non-treatment

U.S.A. Marie Zahorick, APRN, MS, FNP-C, IBCLC
Abstract:

If you have worked with mothers for more than a few weeks, you have encountered a mother with mental illness. You may not have recognized the symptoms while talking with your patient. Or, you may wonder if a certain psychiatric medication is “safe” during lactation.

Perinatal mood and anxiety disorders (PMAD) include a spectrum of common mental health disorders: depression, panic disorder, obsessive-compulsive disorder, posttraumatic stress disorder, bipolar disorder, and postpartum psychosis.

These disorders often ruin enjoyment of the postpartum experience and bonding with the baby. Perinatal bipolar disorder and postpartum psychosis are particularly dangerous due to severe depression and reckless or bizarre behavior that can endanger mother and baby.

Medicating the lactating mother is a careful balancing act between the health and safety of the mother and the health and safety of the baby. But failing to medicate a mother with PMAD can lead to misery, dysfunction, poor infant outcomes and in the worst situations, injury and death.

This presentation will give an overview of the different classes of antidepressants, antianxiety medications, antipsychotics, and mood stabilizers commonly used in breastfeeding mothers. Electroconvulsive therapy and transcranial magnetic stimulation will also be discussed as non-pharmacologic treatments.

View Full Presentation Information
Duration: 60 mins
Luke Grzeskowiak, PhD, BPharm(Hons), GCertClinEpid, AdvPracPharm, FSHP
An Evidence-Based Guide to Using Domperidone as a Galactagogue
Australia Luke Grzeskowiak, PhD, BPharm(Hons), GCertClinEpid, AdvPracPharm, FSHP

Associate Professor Luke Grzeskowiak is a clinical pharmacist and Practitioner Fellow in the College of Medicine and Public Health at Flinders University and the South Australian Health and Medical Research Institute, Australia. He is passionate about improving health outcomes for mothers and babies through the development and promotion of more effective and safer approaches towards medicines use. Luke has been undertaken research involving the use of domperidone for 10-years. He is currently the lead investigator on a number of projects examining the use of domperidone to increase breast milk supply in clinical practice, predictors of treatment response to domperidone, and causes of low breast milk supply. He is also the lead investigator on a large clinical trial comparing the effects of different doses of domperidone in the treatment of lactation insufficiency. He has published widely on the topic of treatment for low breast milk supply, with many of these publications cited in clinical practice guidelines locally and internationally.

1. Describe benefits and risks associated with using domperidone as a galactagogue.

2. Describe evidence-based recommendations relating to the commencement and cessation of domperidone.

3. Explain controversies and risk management approaches for using domperidone safely in clinical practice.

Australia Luke Grzeskowiak, PhD, BPharm(Hons), GCertClinEpid, AdvPracPharm, FSHP
Abstract:Whether real or perceived, low breast milk supply remains one of the most commonly reported reasons for early breastfeeding cessation. While non-pharmacological support strategies remain the first-line approach for addressing concerns with low breast milk supply, we know that many women are recommended or turn to using galactagogues (substances thought to promote lactation). Domperidone is one of the most widely recognised and recommended pharmaceutical galactagogues across the world. This presentation will provide an evidence-based overview of the benefits and risks associated with using domperidone as a galactagogue and describe treatment recommendations relating to treatment initiation, dosing, duration of treatment, and treatment cessation. Evidence relating to the association between domperidone and sudden cardiac death and ventricular arrhythmias will also be discussed with a focus on its relevance to lactating women and consideration of risk management approaches that can be utilized in clinical practice to reduce risk of harm.
View Full Presentation Information

Accreditation


CERPs - Continuing Education Recognition Points
Applicable to IBCLC Lactation Consultants, Certified Lactation Consultants (CLCs), CBEs, CLE, Doulas & Birth Educators. GOLD Conferences has been designated as a Long Term Provider of CERPs by IBLCE--Approval #CLT114-07.

This program is approved for 3 L-CERPs.

If you have already participated in any of these presentations, you are not eligible to receive additional credits for viewing it again. Please email [email protected] if you have any questions.

Additional Details:

Viewing time: 4 Weeks

Tags / Categories

(IBCLC) Clinical Skills, (IBCLC) Pharmacology and Toxicology, (IBCLC) Psychology, Sociology, and Anthropology, (IBCLC) Research, Lactation & Breastfeeding, Medications & Herbs

How much time do I have to view the presentations?

  • The viewing time will be specified for each product. When you purchase multiple items in your cart, the viewing time becomes CUMULATIVE. Ex. Lecture 1= 2 weeks and Lecture Pack 2 = 4 Weeks, you will have a total of 6 weeks viewing time for ALL the presentations made in that purchase.
  • Time for viewing the talks begins once you purchase the product. For Live Webinars & Symposiums, the viewing period begins from when the live event takes place. Presentations can be accessed 24/7 and can be viewed as many times as you like during the viewing period.

What are bundled lectures?

  • Presentations may be available individually or via a bundled package. Bundled lectures are a set of lectures that have been put together based on a specific category or topic. Some lectures will be available in both individual and lecture form, whereas others will be available only via a bundled lecture pack.

Will there be Handouts?

  • YES! Each lecture comes with a PDF handout provided by the Speaker.

Some lectures include a Q&A, what does that mean?

  • During our online conferences, presentations that occur live are also followed by a short 15 minute Question & Answer Session. The Speaker addresses questions that were posted by Delegates during the presentation. We include the recording of these Q&A Sessions as a bonus for you.

How can I receive a Certificate?

  • If this presentation offers a certificate, once you are done viewing the lecture or the lectures within a bundle, submit your attendance record in order to be able to download your certificate. You'll be able to see which credits are offered for the lecture by hovering over the "Credits Available" link within the "Speakers & Topics" tab.
Start Learning Today!

Professionals that selected this package also viewed

Page   1 of 0